A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Active, not recruiting · NCT06848231 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Active, not recruiting | Phase 2 | 2026-08-19 | NCT06848231 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dasher Neuroscience Inc. | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 306 |
| Brigham and Women's Hospital | Boston | United States | 511 |
| Columbia University Irving Medical Center | New York | United States | 234 |
| Juntendo University Hospital | Tokyo | Japan | 12 |
| Mayo Clinic | Rochester | United States | 664 |
| National Taiwan University Hospital | Taipei | Taiwan | 52 |
| National Taiwan University Hospital Cancer Center | Taipei | Taiwan | 2 |
| UCLA Health | Los Angeles | United States | 13 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |